• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
Treat NMD Logo (Copyright)

TREAT-NMD

Advancing diagnosis, care and treatment for people with neuromuscular diseases around the world

Contact us

header-right

  • Home
  • Who We Are
    • About Us
    • Partnerships and Collaborations
    • Governance
    • Our Team
  • Who We Support
    • Patients
    • Clinicians / Researchers
    • Life Sciences Industry
  • What We Do
    • Advisory Committee for Therapeutics
    • The Global Registry Network
    • Core Datasets
    • Education
    • Post-Marketing Surveillance
  • Resources and Support
    • Neuromuscular Disease Information
    • Research Overview
    • Standards of Care & Family Guides
    • SOP Library
    • Social and Ethical Issues
  • Conference
    • Registration
    • Sponsorship Opportunities
    • Conference Programme
    • Sponsors of the TREAT-NMD 8th International Conference
    • Programme Committee
    • Abstracts
    • Venue
  • News & Events
    • News
    • TREAT-NMD Events
    • All Events
    • Submit an Event
    • Newsletter Sign-up
    • Contact Us

Celebrating International Women's Day 2024: Honouring the Inspirational Females of TREAT-NMD and Beyond

Home / TREAT-NMD News / Celebrating International Women’s Day 2024: Honouring the Inspirational Females of TREAT-NMD and Beyond
TREAT-NMD celebrates IWD2024

Celebrating International Women’s Day 2024: Honouring the Inspirational Females of TREAT-NMD and Beyond

As we celebrate International Women’s Day 2024, TREAT-NMD proudly acknowledges and honours the extraordinary contributions of the fantastic females within our organisation and the inspiring women we collaborate with in the neuromuscular field. Today, we reflect on the profound impact these individuals have made in advancing research, patient care, and advocacy.

TREAT-NMD’s Dynamic Women: A Force for Change

At TREAT-NMD, we are proud to have a diverse and dynamic team of fantastic females who play pivotal roles in driving our mission forward. These remarkable individuals embody the spirit of inclusion, contributing their unique talents, perspectives, and expertise to create a collaborative and empowering environment. Find out more about these remarkable individuals here > Meet our team Their dedication to advancing research, patient care, and advocacy is truly commendable. Each of them contributes to the inclusive culture that defines TREAT-NMD, fostering an environment where everyone’s contributions are valued.

Collaboration with Inspiring Women in the NMD Field

TREAT-NMD recognises that progress is fuelled by collaboration. We are privileged to work with a network of inspiring women who share our dedication to advancing the understanding and treatment of neuromuscular disorders. Among them, we want to spotlight the following exceptional individuals:

Duchenne UK: Emily Reuben and Alex Johnson

The dynamic duo leading Duchenne UK, Emily Reuben and Alex Johnson, exemplify the power of collaboration and determination. Their innovative approaches and tireless efforts contribute significantly to the pursuit of treatments and cures for Duchenne muscular dystrophy.

CureDuchenne: Debra Miller

Debra Miller, the Founder of CureDuchenne, is a trailblazer in the neuromuscular community. Her visionary leadership and unwavering dedication have played a pivotal role in advancing research and providing support for individuals and families affected by Duchenne.

TREAT-NMD Advisory Committee for Therapeutics and Education: Annemieke Aartsma-Rus

Annemieke Aartsma-Rus, Chair of TREAT-NMD’s Advisory Committee for Therapeutics and Education, is a driving force behind inclusive decision-making and collaboration. Her leadership and commitment contribute significantly to shaping the direction of our research and educational programs.

Countless Inspiring Females: A Collective Force

While we celebrate these highlighted individuals, it’s essential to acknowledge that there are countless other inspiring women fundamental to what we do at TREAT-NMD. Unfortunately, it’s impossible to name them all individually, but their collective impact is woven into the fabric of our organisation.

On this International Women’s Day, TREAT-NMD reaffirms its commitment to fostering an inclusive environment, where the diverse contributions of women drive progress in neuromuscular research and patient care. Together, we stand as a collective force, empowered to create positive change in the lives of those affected by neuromuscular disorders.

Happy International Women’s Day!

8 March 2024

Primary Sidebar

  • Home
  • Who We Are
    • About Us
    • Partnerships and Collaborations
    • Governance
    • Our Team
  • Who We Support
    • Patients
    • Clinicians / Researchers
    • Life Sciences Industry
  • What We Do
    • Advisory Committee for Therapeutics
      • Members of the Advisory Committee for Therapeutics
      • Take Part in TACT
      • Past Applicants
    • The Global Registry Network
      • Members of the Registry Network
    • Core Datasets
      • DM dataset
      • DMD dataset
      • FSHD dataset
      • LGMD
      • SMA
    • Education
      • Masterclasses and Events
      • Digital Resources
      • Endorsement of External Programmes
    • Post-Marketing Surveillance
  • Resources and Support
    • Neuromuscular Disease Information
      • Becker muscular dystrophy
      • Charcot-Marie-Tooth
      • Congenital muscular dystrophy
      • Congenital myasthenic syndromes
      • Duchenne muscular dystrophy
      • Facioscapulohumeral muscular dystrophy
      • GNE myopathy
      • Limb girdle muscular dystrophy
      • Myotonic dystrophy
      • Myotubular and centronuclear myopathies
      • Spinal muscular atrophy
    • Research Overview
      • DMD
        • Gene Therapy for DMD
        • Mutation Specific Approaches
        • Cell Therapy
        • Drug Therapy
    • Standards of Care & Family Guides
      • CM Care
      • CMD Care
      • DM Care
      • DMD Care
      • BMD Care
      • FSHD Care
      • SMA Care
    • SOP Library
      • MDX Mouse (DMD)
      • GRMD Dog (DMD)
      • CMD Mouse (CMD)
      • SMA Mouse (SMA)
      • CMD animal models
      • MDC1A Preclinical Research
      • Cell Lines
        • Clinical Outcome Measures
        • Functional Evaluation Tools
        • NMR (MRI/MRS) Imaging
        • Muscle Biopsy
    • Social and Ethical Issues
  • Conference
    • Registration
    • Sponsorship Opportunities
    • Conference Programme
    • Sponsors of the TREAT-NMD 8th International Conference
    • Programme Committee
    • Abstracts
    • Venue
  • News & Events
    • News
    • TREAT-NMD Events
    • All Events
    • Submit an Event
    • Newsletter Sign-up
    • Contact Us

Footer

Contact us

4th Floor
The Catalyst
Newcastle upon Tyne
NE4 5TG
United Kingdom
info@treat-nmd.com

Links

Home
Who we are
What we do
Who we support
Resources & support
Connect with us
Privacy Policy
Cookies

Newsletter Sign Up

Sign up to our monthly newsletter

 
ISO 27001 Accreditation Logo

Connect

info@treat-nmd.com
TREAT NMD © 2025
Privacy Policy
Sitemap
STCS LTD

  • Home
  • Who We Are
    • About Us
    • Partnerships and Collaborations
    • Governance
    • Our Team
  • Who We Support
    • Patients
    • Clinicians / Researchers
    • Life Sciences Industry
  • What We Do
    • Advisory Committee for Therapeutics
      • Members of the Advisory Committee for Therapeutics
      • Take Part in TACT
      • Past Applicants
    • The Global Registry Network
      • Members of the Registry Network
    • Core Datasets
      • DM dataset
      • DMD dataset
      • FSHD dataset
      • LGMD
      • SMA
    • Education
      • Masterclasses and Events
      • Digital Resources
      • Endorsement of External Programmes
    • Post-Marketing Surveillance
  • Resources and Support
    • Neuromuscular Disease Information
      • Becker muscular dystrophy
      • Charcot-Marie-Tooth
      • Congenital muscular dystrophy
      • Congenital myasthenic syndromes
      • Duchenne muscular dystrophy
      • Facioscapulohumeral muscular dystrophy
      • GNE myopathy
      • Limb girdle muscular dystrophy
      • Myotonic dystrophy
      • Myotubular and centronuclear myopathies
      • Spinal muscular atrophy
    • Research Overview
      • DMD
        • Gene Therapy for DMD
        • Mutation Specific Approaches
        • Cell Therapy
        • Drug Therapy
    • Standards of Care & Family Guides
      • CM Care
      • CMD Care
      • DM Care
      • DMD Care
      • BMD Care
      • FSHD Care
      • SMA Care
    • SOP Library
      • MDX Mouse (DMD)
      • GRMD Dog (DMD)
      • CMD Mouse (CMD)
      • SMA Mouse (SMA)
      • CMD animal models
      • MDC1A Preclinical Research
      • Cell Lines
        • Clinical Outcome Measures
        • Functional Evaluation Tools
        • NMR (MRI/MRS) Imaging
        • Muscle Biopsy
    • Social and Ethical Issues
  • Conference
    • Registration
    • Sponsorship Opportunities
    • Conference Programme
    • Sponsors of the TREAT-NMD 8th International Conference
    • Programme Committee
    • Abstracts
    • Venue
  • News & Events
    • News
    • TREAT-NMD Events
    • All Events
    • Submit an Event
    • Newsletter Sign-up
    • Contact Us